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Abstract
Background—The relationship between cardiac autonomic nerve activity and blood pressure
(BP) changes in ambulatory dogs is unclear.
Objective—To test the hypotheses that simultaneous termination of stellate ganglion nerve
activity (SGNA) and vagal nerve activity (VNA) predisposes to spontaneous orthostatic
hypotension and that specific β2 adrenoceptor blockade prevents the hypotensive episodes.
Methods—We used a radiotransmitter to record SGNA, VNA and blood pressure (BP) in 8
ambulatory dogs. Video imaging was used to document postural changes.
Results—Out of these 8 dogs, 5 showed simultaneous sympathovagal discharges in which the
minute by minute integrated SGNA correlated with integrated VNA in a linear pattern (“Group
1”). In these dogs abrupt termination of simultaneous SGNA-VNA at the time of postural changes
(as documented by video imaging) was followed by abrupt (>20 mmHg over 4 beats) drops in BP.
Dogs without simultaneous on/off firing (“Group 2”) did not have drastic drops in pressure. ICI
118,551 (ICI, a specific β2-blocker) infused at 3.1 µg/kg/hr for 7 days significantly increased BP
from 126 (95% confidence interval, CI: 118 to 133) mmHg to 133 (95% CI 125 to141) mmHg
(p=0.0001). The duration of hypotension (mean systolic BP < 100 mmHg) during baseline
accounted for 7.1% of the recording. The percentage was reduced by ICI to 1.3% (p = 0.01).
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Conclusions—Abrupt simultaneous termination of SGNA-VNA was observed at the time of
orthostatic hypotension in ambulatory dogs. Selective β2 adrenoceptor blockade increased BP and
reduced the duration of hypotension in this model.
Keywords
Ambulatory nerve recording; orthostatic hypotension; beta blockade
It is well-established that the autonomic nervous system (ANS) is important in controlling
not only heart rhythm and contraction, but also the vasomotor tone and systemic blood
pressure (BP). Chronic stimulation of the stellate ganglion can cause hypertension in dogs,1
suggesting that elevated stellate ganglion nerve activity (SGNA) is a cause of hypertension.
While sympathetic activation may cause vasoconstriction by activating α-1 adrenoreceptors,
sympathetic activation can also activate β2 adrenoreceptors to cause vasodilation.2, 3 In
addition to its effects on peripheral vascular resistance, the autonomic nervous system also
controls heart rate that impacts diastolic filling, stroke volume, cardiac output and hence
systemic BP. To better understand the ANS control of cardiac function, we have developed
methods to simultaneously record stellate ganglion nerve activity (SGNA) and vagal nerve
activity (VNA) in ambulatory dogs.4–6 Preliminary data demonstrated that the stellate
ganglion and vagal nerve do not fire independently of each other. Rather, there is a high
degree of coordination between these two nerve structures, and the patterns of correlation in
part determine the spontaneous occurrences of atrial tachyarrhythmias.7, 8, 9 Whether or not
the patterns of SGNA-VNA correlation play a role in BP control of ambulatory dogs
remains unknown. We therefore performed a study to simultaneously record SGNA, VNA
and brachial artery BP in ambulatory dogs to determine if the patterns of SGNA-VNA
coordination influence BP control. We unexpectedly observed an association between
simultaneous SGNA-VNA termination and orthostatic hypotension. This observation gave
us the opportunity to test the effects of pharmacological intervention on the hypotensive
episodes. We chose to first test the hypothesis that a non-selective β blocker and α1 blocker
(carvedilol) can prevent these hypotensive episodes. This was followed by the infusion of
ICI-118,551 (ICI), a specific β2 adrenoceptor blocker10, 11 in the same dogs.
Materials and Methods
The study protocols were approved by the Institutional Animal Care and Use Committee of
the Indiana University School of Medicine and the Methodist Research Institute,
Indianapolis, Indiana.
Study Protocol
Left thoracotomy was performed through the first intercostal space for the implantation of a
D70-CCTP radiotransmitter manufactured by the Data Sciences International (DSI, St Paul,
MN in 8 mongrel dogs (4 male, weighing 20–30 kg). The first pair of bipolar electrodes was
used to record from left stellate ganglion and a second pair was used to record from left
thoracic vagal nerve at the level 4 to 5 cm above the aortic arch. A third lead (a catheter with
a pressure sensor) was inserted directly into the subclavian artery for BP recording. The
transmitter and ground wires were inserted into a subcutaneous pocket. The chest wall was
then closed. After 2 weeks of recovery, the radiotransmitter was turned on to record nerve
signals and BP at baseline. The pre-implantation BP was calibrated against the ambient
pressure in the vivarium. There was 12 hr daylight cycle in the vivarium starting at 7 AM
each day. After 24-hr baseline (SGNA, VNA, and BP) recordings, the dogs were given oral
carvedilol, 12 mg twice daily for a week. The drugs were then washed out for a week and
baseline recordings were re-collected at the end of the week. Sterile surgery was then
performed for the subcutaneous implantation of a 2 ml osmotic pump (model 2ML1, Alzet
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Inc., Cupertino, CA). The pump contained 2 ml of ddH20 and 18 mg of ICI 118,551 (ICI), a
specific inhibitor of β2 adrenoceptor.10 The pump is designed to empty its contents over 7
days at a rate of 10 µl/hr. Therefore, the infusion rate is 3.1 µg/kg/hr for a 30 kg dog. The
infusion rate at which half the β2 receptors are saturated has been reported to be 2 µg/kg in
beagles.10 The data collected at days 6–7 of the infusion were used for analyses. A week
after completing this stage of drug infusion, the dogs were euthanized.
Data analyses
Nerve activity analyses—Nerve activities were analyzed both manually and with
computerized methods.12 The nerve activities were integrated minute by minute. We
manually reviewed the data of all dogs and selected for analyses the first 10 noise-free min
of each hour. The mean BP was also analyzed minute by minute during the same period.
The SGNA was plotted against the VNA on an XY graph to visualize the patterns of
activation.12, 13
Statistical analyses—To determine the relationship between BP, heart rate and ANS
activities, we computed 1-min and 4- hour average for each dog on each day of data
collection starting from midnight. Pearson correlation coefficients between SGNA and VNA
were also calculated within each 4-hour interval. To analyze data from all dogs and the 4-
hour average data, a random effects model with dog as the random effect was used with the
same dependent and independent variables, plus heart rate and the Pearson correlation
coefficient as additional independent variables. Random effects models were also used to
compare the effects of the drugs on the proportion of hypotensive episodes (average
SAP<100mmHg) using data from all dogs, which includes the main effects of drug and the
six 4-hour intervals and their interactions. In this model, the correlations of the multiple 4-
hour data points from the same dog is accounted for by treating dog as random effect. A
cubic smoothing spline was also used to fit BP versus hour for one dog. Statistical analysis
was performed with IBM SPSS Statistics 19 and SAS version 9.3. A two –sided p value of ≤
0.05 was considered statistically significant.
Results
Relationship between autonomic nerve activity and BP
Each dog was monitored for an average of 10 weeks (range 6 to 21 weeks) during which
SGNA, VNA and BP were intermittently collected. There are two basic patterns of nerve
activity.8 In the first pattern (termed “Group 1” in that report), the SGNA and VNA activate
simultaneously (Figure 1A and 1B). A plot of integrated stellate ganglion nerve activity
(iSGNA) vs. integrated vagal nerve activity (iVNA) gives a linear pattern (Figure 2A). Five
of the eight dogs initially demonstrated Group 1 firing at baseline. We found that the
SGNA-VNA correlation is important in BP control. In general, simultaneous sympathovagal
firing was associated with a higher mean BP, while there were more extreme drops in BP at
the time of simultaneous sympathovagal termination. Figure 1A shows a Group 1 dog with a
baseline BP ranging from 75 to 100 mmHg and heart rate averaging 162 bpm. At the start of
the simultaneous low amplitude sympathovagal discharge (asterisk), the blood pressure
increased rapidly. An abrupt increase in BP (red arrow) is followed by sustained and large
amplitude simultaneous sympathovagal discharges without an apparent initial increase in
heart rate. Figure 1B shows that after 68 seconds of continuous sympathovagal discharge,
the nerve activity abruptly and simultaneously terminates. This is followed by a rapid drop
in BP to as low as 65 mmHg systolic and 45 mmHg diastolic (black arrow) and tachycardia.
The BP then gradually recovers, assisted by low amplitude intermittent SGNA (asterisks).
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The second pattern of nerve activity (Group 2) where SGNA and VNA activate separately is
shown in Figure 1C. Note that the independent activation of SGNA (asterisk, first line) is
associated with elevated BP (red arrow) while VNA (asterisk, second line) is associated with
a lower mean arterial blood pressure and heart rate. Figure 1D shows a second dog in which
SGNA and VNA activate separately - here the vagus nerve activates alone during the first
eight seconds of the recording. This activation is associated with bradycardia (black arrow).
The sympathetic bursts were low amplitude (asterisks) in the beginning, which are
associated with brief increases in heart rate (red arrows). This was then followed by large
increase of SGNA and a simultaneous drop of BP. Complete cessation of SGNA and
continuous VNA was associated with bradycardia (second black arrow).
Changing sympathovagal correlation
A previous study that monitored canines for approximately 2 months8 suggested that the
sympathovagal correlation is static. However, recordings done in the present study over a
longer time frame (5–6 months) demonstrate that patterns of sympathovagal correlation
evolve over time. This is best illustrated by dog #1 that was monitored over 6 months, as
shown in Figure 2. This dog started out during the monitoring period (July) as a Group 1
dog (Figure 2A). At that time, the dog was 6 months old and weighed 30.1 Kg. Slowly, over
months, he evolved into a Group 2 dog (Figures 2B–D). The weight increased to 40.3 Kg in
December. The iSGNA and iVNA have drastically dropped in December. There were
increasing SGNA at the time when VNA was silent. This nonlinear relationship between
SGNA and VNA indicates a complex interaction between SGNA and VNA. Other dogs
stayed in the same group throughout the recording, although the patterns of correlation
changed slightly over time. While Figure 2A suggests that a high r value between iSGNA
and iVNA is associated with high systolic BP, statistical analyses of all dogs studied failed
to support this correlation.
ANS and BP
The ANS activity in all dogs studied is significantly associated with BP changes. Each mV-s
increase of iSGNA is associated with 0.04580 mmHg increase in BP (p=0.0478). Each mV-s
increase of iVNA is associated with an insignificant decrease in BP of −0.05484 mmHg
(p=0.0648). Heart rate (p=0.9991) and the SGNA-VNA correlation coefficient (p=0.1294)
are not associated with BP changes using analyses summarized by 4 hour intervals.
Abrupt hypotensive episodes
In Figure 1B, abrupt cessation of simultaneous sympathovagal discharges seen in Group 1
dogs was associated with an abrupt drop in BP. To determine if these episodes were related
to postural changes, we installed video cameras in the dog kennel and monitored nerve
activity, BP and video recordings simultaneously. Several patterns of behavior emerged as is
shown in Figure 3. The first pattern is illustrated in Figures 3A–C. Figure 3A shows
simultaneous firing of the canine’s sympathetic and vagal nerves. The green bar indicates
the time the video in Figure 3B was captured; red bar is the time Figure C was captured.
Note that the dog is lying down during simultaneous sympathovagal discharge (Figure 3A).
Abrupt termination of the nerve discharges coincides with a change in posture from lying to
sitting up (Figure 3B–C). This was accompanied by an abrupt drop in the mean arterial
pressure from 80 mmHg to 60 mmHg, a dramatic narrowing of the pulse pressure and an
acceleration of heart rate. We have reviewed the video imaging collected in 3 dogs and
analyzed a total of 1000 episodes of abrupt simultaneous termination of sympathovagal
discharges. Among these episodes, 390 were associated with sudden movement, such as
standing up or starting to jump. In some episodes it appeared that the dog was aroused
(Figure 3A). The second pattern of behavior is illustrated in Figures 3D–E from a different
dog. The dog was lying quietly on the floor and remains lying down during both the
Hellyer et al. Page 4
Heart Rhythm. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
simultaneous sympathovagal discharges (green line) and after the abrupt termination of the
firing (red line). Note in Panel D there is only mild drop in BP (from 110 mmHg to 100
mmHg) without narrowing of the pulse pressure. There is tachycardia after the termination
of sympathovagal discharges.
Figure 4 shows the circadian variation of the hypotensive episodes. Figure 4A shows an
example of extreme hypotension in the same dog as in Figure 1. The BP dipped to as low as
20 mmHg. We manually analyzed the distribution of similar episodes (drop in pressure of 20
mmHg over 4 beats) throughout the day and found that there is a significant (p<0.0001)
circadian variation of the hypotensive episodes associated with sympathovagal termination
(Figure 4B).
Effects of drugs on BP
Figure 5 illustrates the relationship between SGNA, VNA and BP during baseline,
carvedilol and ICI infusion across all eight dogs. In panel A, each dot represents the average
of 4 hours of integrated nerve activity; in panel B, each dot is one minute of integrated nerve
activity. The red line is drawn to mark 100 mmHg. Note the substantial increase in mean
systolic BP between baseline and ICI recordings, but not between baseline and carvedilol in
Panel A. The mean BP (calculated over 4 hour intervals) during ICI infusion does not dip
lower than 110 mmHg in any dog (red arrows). In Panel B, each dot represents the mean
systolic BP over one minute. The number of hypotensive episodes (defined as mean systolic
pressure <100mmHg in that one minute) were calculated for each dog. The percentage of
hypotensive episodes during baseline was 7.1%; after carvedilol, 7.8% (p = 0.7475) and
after ICI, 1.3% (p = 0.0110). These data show that ICI, but not carvedilol, significantly
reduces hypotensive episodes.
Discussion
Autonomic Nerve Activity and Postural Hypotension
Dogs are quadruped while humans are biped. Dogs may not be optimal models for human
orthostatic intolerance. However, in spite of this limitation, there are significant similarities
between the results of this study and that found in human muscle sympathetic nerve activity
(MSNA) studies during tilt table testing.14–19 Typically, upright tilt immediately increases
the MSNA. An acute reduction of MSNA and BP is observed in patients with vasovagal
syncope but not in the controls.14 These findings are similar to that observed in Group 1
dogs, when abrupt termination of SGNA is associated with abrupt drop in BP. They support
the hypothesis that the final trigger for orthostatic hypotension is sympathetic nervous
system inhibition. However, in a more recent study,15 the authors found that efferent
sympathetic nerve traffic to the skeletal muscle vasculature (i.e., MSNA) is nearly always
maintained through the faint. The authors of the latter study propose an alternative
viewpoint, that vasodilator mechanisms underlie the blood pressure fall in vasovagal
syncope. Similar findings were also reported by Fu et al.20 Because of these new findings, it
has been proposed that vasovagal syncope is a heterogeneous condition and that there are
different drivers in different group of patients.21 In our canine model, the Group 2 dogs also
have intermittent reduction of BP, although not as severe as in Group 1 dogs. Typically
elevated BP triggers a large increase of SGNA and a reduction of BP. The continuation of
SGNA during BP reduction is similar to that found in some human patients with vasovagal
syncope.15, 20
The contribution of vagal nerve
In our study, the VNA (or lack thereof) seems to be important in BP control. For example,
simultaneous activation of VNA in Group 1 dogs may counterbalance the effects of SGNA
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and help maintain a relatively normal heart rate. These findings suggest that SGNA is the
primary phenomenon while VNA is the secondary phenomenon that counterbalanced the
SGNA for BP and heart rate control. Abrupt termination of VNA allowed heart rate to
increase, which leads to an increased cardiac output and normalization of the BP after
transient orthostatic hypotension. Absence of VNA in Group 2 dogs implies that
sympathetic tone alone controls the BP changes through vasoconstriction, vasodilation and
heart rate modulation. The differential patterns of VNA in these two groups of dogs suggest
that more than one mechanism play a role in the development of intermittent hypotensive
episodes in dogs. The importance of VNA in hypotensive episodes in each dog is
complicated by the fact that the grouping of dogs may change over time. In addition, due to
the complex physiology associated with vagal nerve activation, quantitative analyses using
integrated vagal nerve activity may not be an optimal method to assess the vagal tone. The
contribution of vagal nerve in hypotension requires further study.
Therapeutic implications
The prevention of syncope trial (POST)22 showed metoprolol (a selective β1 blocker) is not
an effective therapy for vasovagal syncope in humans. In comparison, our data show that
selective β2 blocker may prevent the hypotensive episodes. In Group 1 dogs, β2 blocker may
selectively prevent vasodilation effects of sympathetic activation during the large SGNA.
When SGNA abruptly terminates, the residual cardiac stimulation effects of β1 activation
may prevent precipitous drop of BP. In Group 2 dogs, β2 blocker may directly inhibit the
vasodilation during large sympathetic surge. We used ICI, a specific β2 adrenoceptor
blocker,10, 11 to test this hypothesis. The results showed that ICI lead to an overall increase
in BP and an elimination of the hypotensive episodes in ambulatory dogs. Our results are
consistent with a previous study in a rat model of orthostatic hypotension, which showed
that β1-adrenoceptors played a role in compensatory tachycardia reflex and β2-
adrenoceptors in blood pressure reflex.23 The latter conclusion is supported in part by the
finding that ICI had a tendency to improve orthostatic symptoms in that rat model. Our
findings may also help explain the mechanisms by which non-selective β blockers
(propranolol and nadolol) improve the symptoms of vasovagal syncope.24
In addition to implications for drug therapy, the present study is also relevant to
nonpharmacological therapies of vasovagal syncope. A recent study showed that endocardial
ablation of the intrinsic cardiac nerves is effective in the treatment of vasovagal syncope in
human patients.25 That procedure benefited not only cardioinhibitory type but also
vasodepressor and the mixed types of vasovagal syncope. Because of these observations, the
authors suggested that endocardial ablation procedure might have affected the nerve
structures outside of the heart to achieve its therapeutic benefits. Other studies show that
renal sympathetic denervation is effective in treating drug refractory hypertension.26 These
findings suggest that the autonomic nerve structures are interconnected both functionally
and anatomically to achieve BP control. Better understanding of ANS control of BP may
help further development of the neuromodulation procedures for clinical application.
Limitation of the study
Because humans are biped and dogs (as well as rats and many other laboratory animals) are
quadruped, it is difficult to develop an optimal canine model of human orthostatic
intolerance. Therefore, whether or not our observations are applicable to humans remain
unclear. Unlike humans, the symptoms associated with orthostasis are difficult to ascertain.
Due to the limitation of recording devices, we were only able to measure the autonomic
nerve activities on the left side of the body. While the autonomic nerves of the right and left
side of body often activate together,4, 27 the absence of right sided recording is a limitation.
The absolute values of integrated nerve activity may be affected by technical factors such as
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the amount of scarring, the size of the stellate ganglion and the electrode orientation to the
axis of electrical activity. However, the moment to moment correlation of sympathetic and
vagal nerve activities is likely to be independent of these technical factors. The duration of
the recording is not long enough to determine if there are seasonal variations of the iSGNA-
iVNA correlations. A previous clinical study showed that ICI (in doses up to 80 mg orally)
has no side-effects to humans.11 However, all drugs have potential side effects. The absence
of apparent side effects in dogs does not rule out the potential side effects for humans,
especially on long term use.
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Figure 1.
Representative autonomic nerve activity. Panel A: examples of simultaneous sympathovagal
co-activation in a Group 1 dog. Asterisk indicates the start of nerve firing which occurs a
few seconds prior to increase in blood pressure. Panel B: Same dog as panel A; termination
of sympathovagal firing after 68 seconds (not shown) of continuous firing. Note that the end
of firing is followed by a sharp decrease in blood pressure. The VNA is quiescent but
intermittent small bursts of SGNA (asterisks) were present. Panel C: Group 2 dog; note the
separate sympathetic and vagal firing, as marked by asterisks. SGNA was associated with
increased heart rate and BP (red arrow). VNA was associated with reduced heart rate and
BP. Panel D. Solitary sympathetic nerve firing associated with transient increases in blood
pressure (red arrows) followed by tachycardia and reduction of BP. Black arrows indicate
bradycardia, which are associated with VNA at times when SGNA was inactive. A filled
black circle marked the time when the amplitude of BP was too small for heart rate
determination. HR, heart rate.
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Figure 2.
Evolution of the SGNA-VNA correlation over time in dog #1, which has been monitored for
over 6 months. Panel A shows that the dog had a linear SGNA-VNA correlation in July.
Each dot represents SGNA and VNA activity integrated over 60s. The patterns gradually
changed to L-shaped SGNA-VNA correlation in December. Mean systolic arterial blood
pressure and correlation are shown for each graph. There is no apparent relationship
between the correlation patterns and the mean Systolic blood pressure (SBP).
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Figure 3.
Autonomic nerve activity and postural hypotension. Panels A–C: Orthostatic hypotension in
dog #1. A shows simultaneous SGNA, VNA and BP recordings; video recordings were
taken during the same time (Panels B and C). The green line marks the time in the recording
that corresponds to Panel B and the red line marks the time for C. Note the simultaneous
sympathovagal discharge while the dog is lying quietly (B). The termination of
sympathovagal discharge occurs when the dog stands up (C) and resulted in a large (>20
mmHg) change in BP. Panels D–F: Dog #2 shows no change in position from E to F. Note
the cessation of sympathovagal discharge at the same time. However, there was only a small
drop in BP (~10mmHg) without changes in position. HR, heart rate.
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Figure 4.
Circadian variation of the hypotensive (< 70 mmHg) episodes. Panel A shows a
representative hypotensive sample. Note that the hypotensive episode occurs after abrupt
termination of sympathovagal discharge. A filled black circle marked the time when the
amplitude of BP was too small for heart rate determination. HR, heart rate. Panel B shows a
catalogue of all hypotensive episodes in two different days, one week apart, fitted with a
cubic smoothing spline (solid line). The hypotensive episodes were defined as a drop of 20
mmHg in BP over no more than 4 heart beats. The dashed lines are the point-wise 95%
confidence intervals. There is strong evidence of circadian variation. P < 0.001.
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Figure 5.
Effects of drugs on BP distribution. In Panel A, each dot represents an averaged systolic BP
over 4 hr recording period. The dogs are color coded, showing heterogeneous BP
distribution among dogs. The BP did not drop below 100 mmHg during ICI infusion (red
arrows). Each dot in Panel B shows the average systolic BP over a 1-min period. Data from
all dogs are shown with the same color. ICI reduced the probability of BP dropping below
100 mmHg (red arrows).
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